Recent attempts
to clarify the pathogenesis of pharmacoresistant epilepsies arrive at the conclusion that intractable epilepsies might be prevented by earlier, more effective pharmacotherapy.
In this paper the problem of intractability is examined from a psychological point of view.
Sixteen patients with intractable epilepsies were trained in techniques of self control (SC) in addition to ongoing pharmacological treatment.
The 
INTRODUCTION
In spite of recent developments of new antiepileptic drugs 3040% of patients with epilepsy do not become seizure-free using currently available anticonvulsants. Several recent attempts have been made to better understand the pathogenesis of and to help prevent the development of intractable epilepsies. The traditional view has been that patients with intractable epilepsies have more severe epilepsies-too severe to be controlled with currently available drugs. Reynolds and others I-3 consider the 'alternative or additional possibility that chronicity is not inevitable, that epilepsy should be viewed as a process and that to some extent intractable epilepsy might be prevented by earlier more effective treatment'". Seizure control should be obtained within the first 2 years of treatment5. Bourgeois6 argues on the same line: 'intractability can be defined in broad terms as the failure of optimal therapy'. In his study, 'optimal therapy' meant optimal pharmacological treatment with available antiepileptic medication.
Heinemann' stressed that many drug-resistant epilepsies start in childhood and concludes that 'in most cases drug-resistance appears to be an acquired phenomenon which may well have to do with effects of seizures on the developing brain'. Though strongly supporting the idea of epilepsy as a process as well, Heinemann' seems less optimistic than Reynolds' and Bourgeois6 concerning the efficacy of already available anticonvulsants. He proposes detailed studies to better understand the development of drug-resistant epilepsies and to conceive strategies 'which not only increase the likelihood that new anticonvulsants improve quality of life by improving seizure control with fewer sideeffects but also prevent progression of epilepsies into a pharmacoresistant state. Drugs are also required which provide seizure control for such patients".
Besides these medical and pharmacological considerations to reduce or prevent pharmacoresistance in epilepsy, there is a paucity of systematic attempts to reduce seizure frequency in patients with intractable epilepsies with the help of psychological methods of seizure control.
In this paper a research project is presented in which 20 patients, most of them with pharmacoresistant epilepsies, were offered training in techniques of 'self control' (SC) (non-medical, behavioural measures of seizure control) in addition to ongoing pharmacological treatment. Though the study did not address the question of pharmacoresistance in a direct way, success and failure of the SC programme provided both an insight into conditions which may lead to problems of seizure control, including pharmacoresistance, and new ideas on how to reduce seizure frequency in intractable epilepsies or even to prevent the development of pharmacoresistant epilepsies.
MATERIALS AND METHODS
The treatment model of self control Figure 1 shows the main aspects of SC treatment9-16. Starting from the medical diagnosis 'epilepsy', therapist and patient try to analyse the prephase and the very beginning of the seizure in as much detail as possible.
The focus is on the 'warning signals' ' ' of the seizure (the 'aura' or other feelings or warnings) and on the seizure-provoking factors (triggering factors) which increase the risk of seizure development for the individual patient. Provoking or promoting factors may consist of external (situational) conditions or internal (emotional) states of the patient or a combination of both. On the basis of these additional diagnostic data behavioural measures of seizure control, so-called 'counter measures' 13, are developed: either counter measures to directly interrupt or arrest"' a beginning seizure, or measures to avoid, compensate for, or actively eliminate provoking factors.
At best, a first improvement of the seizure situation can be achieved within three to five sessions and then can be consolidated during another five to ten sessions of SC (see the thick arrow to the box 'Self control' in Fig. 1 ). In most cases, however, there is need for a longer learning process in order for the patient to become more sensitive to warning signals, to identify complex patterns of provoking factors and to create and practice effective counter measures (symbolized by the backwards arrows in Fig. 1) . In some cases it may happen that warning signals and provoking factors have been identified and effective counter measures have been developed, but the patient makes no use of them. The patient may let the onset of the seizure continue without any effort to interrupt it or may even increase the risk of seizure by actively bringing about critical situations. Then an investigation takes place into what possible psychological function(s) the seizures may serve. Sometimes this may require a broader frame of psychotherapy. (For more detailed information on the SC programme applied in this study, see references 14-16.)
Subjects
The 20 subjects participating in the study came from neurological outpatient units of different hospitals. Criteria for inclusion were: (a) clinical electroencephalograph (EEG) evidence of epilepsy, (b) no progressive brain disease, (c), illness of at least 3-year duration, (d) ability to understand and follow instructions, (e) a minimum of four seizures a month, (f) recall of the start of the seizure (i.e. any kind of 'warning signal' and/or early seizure symptoms), (g) unchanged anticonvulsant treatment for at least 1 month prior to participation and no changes for at least another 6 months during SC therapy. For pragmatic reasons (limited time to recruit patients) and because of the exploratory nature of the study we accepted that criteria (e)-(g) were not met by all patients.
The following presentation is based on 16 patients whose epilepsies had been diagnosed as pharmacoresistant by their physicians. In 1 1 patients pharmacoresistance had been diagnosed after treatment with at least three different antiepileptic drugs (AEDs) with the maximal tolerated dose in monotherapy and/or polytherapy. The remaining five patients had been treated with one or two AEDs without becoming seizure-free and no other AED had been assumed to improve seizure control.
Nine of the patients were male, seven female. Nine of them were adolescents, aged 12-17 years, the other seven were adults, aged 21-43 years. Half of the patients had complex partial seizures, in addition, three of them had secondarily generalized grand ma1 (GM) seizures, four patients suffered from GM seizures alone (two primarily generalized, two secondarily generalized). The remaining four patients had simple partial seizures, three of them with additional secondarily generalized GM seizures (see Table 1 ).
Seizure frequency varied from one seizure within 6 weeks to 150 seizures per month. All patients had at least a 5-year history of epilepsy, the majority of them much longer (average duration: 9.9 years). The prescribed AEDs at the outset of the study are shown in the last column of Table 1 . Twelve of the patients were treated with one AED (mostly a high-dose monotherapy), the remaining four patients were treated with a combination of two AEDs. 
Course and duration of SC therapy
For all patients the conditions for SC were examined and counter measures were developed according to the scheme outlined in Fig. 1 . The period of continuous SC treatment varied from 3 to 30 months with an average duration of 18 months; during this time the patients participated in 5-40 sessions with an average of 20 sessions. At the beginning all patients were offered four to six individual sessions at 1-to 2-week intervals to find out their individual (special) conditions for self control. Then individual and group sessions alternated at 2-to 4-week intervals. In most cases there were 'booster sessions' 6 and 12 months after the end of the treatment phase, and then a telephone follow-up after 24 months to ascertain long-term seizure frequency and use of SC techniques.
Case report
To illustrate the process of SC therapy, one patient's course of treatment will be described in more detail. Sebastian has a frontal-lobe epilepsy and suffers from complex partial seizures which usually generalize into tonic-clonic GM seizures. We first met when he was 16 years of age, during his stay at the Children's Hospital to improve his antiepileptic drug regimen. This attempt did not lead to a better seizure control (as many had not previously), and he was offered participation in the SC programme.
The behaviour and seizure analysis revealed the following main points.
(1) Seizures occurred repeatedly in situations of conflict, in particular during confrontations with his mother who was the most important person after the separation of his parents. The first GM seizure developed at the age of 11 years during a heavy conflict between his parents.
(2) Sebastian had identified warning signals that preceded his seizures: he felt tickling in his left arm.
(3) Surprisingly, he had already developed a strategy to counteract his seizures: he stopped breathing for a moment, put his hands to his temples or pressed the bridge of his nose with two fingers of his left hand, closed his eyes tightly and concentrated by saying to himself: 'I don't want to have a seizure now' or 'I don't need a seizure'. This counter measure proved to be effective, when he really did not want to have a seizure. He admitted, however, that he sometimes let a seizure continue to develop to frighten his mother or to be allowed to skip a test at school.
During a further stay in hospital Sebastian was encouraged, and agreed, to try his techniques of SC in a more systematic way. He accomplished a seizurefrequency reduction from five to one or two GM seizures per week.
To come to terms with the critical situations with his mother he was offered continued SC therapy after discharge from hospital. This outpatient therapy, though fully agreed upon by Sebastian, was later prevented by unforeseen reasons: shortly after Sebastian's discharge from the hospital he had to move with his mother into the apartment of her new friend. The relocation to another district implicated a school change which in turn caused massive learning problems for him, hence his seizure control deteriorated.
He needed inpatient treatment again, and this time the decision was made to send him to an epilepsy centre away from his home town. There he was not only offered an integrated medical-psychological treatment programme but also could work on his profound psychological problems at a safe distance from his mother and all the stressing social and situational factors.
Sebastian learned to deal with conflicts in a more courageous way, he gained self confidence and learned to express aggression in a more open manner-instead of indirectly reacting with a seizure. He applied his counter measures actively and successfully. After three seizure-free weeks, and a 2-month stay in the epilepsy centre, he was told of his discharge: he reacted with a GM seizure. His fears of returning home were dealt with. Additionally he was offered a place in a special boarding school 10 kilometres from his mother's residence where he could stay during the week: he agreed to this.
Only a few weeks later he moved to his new home, the boarding school. The relationship with his mother became less tense and he could express himself in an open way. For weeks he remained seizure-free, aborting the majority of onset of seizures successfully by his counter measure. This situation of seizure control remained stable: during the last 2 years he has had only a few GM seizures.
Sebastian's case demonstrates in an impressive way how strongly psychosocial factors can influence the course of epilepsy in a negative or positive way. Situations of psychic stress, in particular feelings of helplessness in the context of conflicts with a more powerful person, not only had a seizure-provoking effect for Sebastian, but also led him to give up his own intuitive means of seizure control. On the other hand, dealing successfully with the problematic situations both weakened their seizure-provoking effect and reduced the functional value of seizures. Sebastian is no longer in need of seizures to resolve conflicts. The anticonvulsant medication, along with his SC techniques, enabled a satisfactory seizure control to develop.
RESULTS
The other patients' courses of SC treatment mostly were less dramatic and often much shorter. Nevertheless, we identified similar factors which proved to be relevant both in respect to the initially existing seizure to the eventually achieved seizure control by SC training at the end of the study. Two groups of factors can be differentiated: 'psychosocial factors' and 'self-control factors'. Table 2 gives an overview of the psychosocial factors identified as having stressing, seizure-facilitating, or otherwise unfavourable effects on the patients' process of epilepsy.
Psychosocial factors
Psychic stress. In 1 1 of 16 patients seizures occurred repeatedly in situations of strong psychic stress. Amongst these seizure-facilitating or provoking factors were conflicts, as in the case of Sebastian (shown in line 1 of Table 2 ), disappointment, feelings of neglect, fear and rage, or pressure to perform.
Functional value ofseizures.
In eight of the 11 patients with identified strong psychic stress factors, seizures had acquired a functional value: either bring to an end the stressful situation, e.g. stop conflict with an important person (as was the case with Sebastian), to attract more attention or to release high demands. Besides being an unpleasant, frightening event, in these cases seizures offered some positive short-term effect to the patients. This kind of functional value may render the treatment of seizures more difficult.
Unfavourable reactions.
There was a third psychological aspect, the meaning of which we recognized only during the course of our study: the so-called 'unfavourable reactions' of the subject. Unfavourable reactions are reactions which the patient shows during situations that carry a high risk for seizures or at the onset of a seizure, and by which the development of the seizure is supported or accelerated.
In seven of the 16 patients such reactions that unwillingly led to increase of seizure risk could be identified. In most cases patients were afraid of their seizures and started hyperventilating or exhibited fear and consequent physiological changes which in turn increased seizure risk. Three patients experienced the additional fear of embarrassment caused by a seizure besides the direct fear of seizures. In all these cases 'warning signals' had lost their positive function of triggering some kind of 'counter measure' to control the seizure. They were misinterpreted as announcing unavoidable danger, became triggering factors for fear and helplessness, and, by that, additional triggering factors of seizures.
One patient had a particularly difficult condition. At the onset of her seizures she had an aura with strong feelings of undefinable fear. She thought she could get rid of her seizures only when she was able to find out the reason of this aura-conditioned fear. By this idea she felt magically attracted into the aura. From the beginning she was unable to resist the seizure as well as not initiating any counter measure to actively interrupt it.
Self control factors
The second group of factors which may contribute to pharmacoresistant epilepsies interfere with the practical performance of SC techniques. This statement is based on the assumption that a number of patients with epilepsy spontaneously try to defend themselves against their seizures, either by aborting their seizures using counter measures or by intuitively avoiding situations that precipitate seizures. Thus, they unconsciously support the effect of the anticonvulsant medication. However, in cases in which these intuitive counteractions are missing or suppressed the effect of the medication may prove to be insufficient. We identified three factors that limit SC (see Table 3 ).
Missing or unclear warning signals.
l Two of our study patients had no warning signals due to the type of epilepsy (primary GM, GM during sleep) and one patient due to his AED. These patients had no chance to use a counter measure to interrupt the onset of a seizure. l Of the remaining 13 patients only three had clear aura-like feelings at the beginning of the study whereas the other 10 patients had unclear, very weak or very rare warning signals.
l Three patients had the additional problem that they could not differentiate seizure warnings from warnings of circulatory dysregulation.
Patients with unclear warning signals not only have a low chance to interrupt the onset of a seizure, but they often give up using their counter measure systematically because they become insecure and disappointed. Unrecognized provoking factors. Unrecognized or ignored provoking factors cannot be compensated. l About half of the patients (five of 11) with psychic triggering factors, described above, at the beginning of the study had never thought of a possible relationship between psychic stress and seizures, and had never tried to diminish their stress in order to lower the seizure risk.
l Besides psychic stress we identified two additional, previously unrecognized, seizure-provoking factors. In one patient high visual input in combination with drowsiness (in part conditioned by the AED) increased seizure risk to a considerable degree. In the other patient seizures tended to develop when he experienced a 'split in concentration' (i.e. situations in which the patient tried to perform more than one activity in parallel, situations of 'divided attention').
Missing, ineffective or unsystematically applied counter measures.
At the beginning of the study four patients had ineffective counter measures (CM).
Three patients performed their effective CM only occasionally (as was true for Sebastian).
For two patients both conditions applied: they occasionally used their ineffective CM.
There was no patient at the beginning of the study with an effective CM used systematically.
Nearly half of the patients (7 of 16) had no CM at all. Whereas three of them had no chance to use a CM because they had no warning signals (see above), the remaining four patients developed no CM despite the presence of warning signals.
It seems remarkable that three of these four patients without CM were adults. Whereas nearly all adolescents spontaneously developed CMs and actively tried to abort their seizures, these three adults did not even develop the idea of a 'counter measure'. On the contrary, two of them were convinced that their seizures were unavoidable. They expected them and prepared themselves to bear the seizure: one patient laid down, waiting until 'all was over'. All three patients succeeded in finding a CM during the course of the study with which they could improve control to a considerable degree. Psychological seizure control The effect of the SC treatment at the end of the study can be summarized as follows (see Table 4 ). All patients who identified illness-related problems (psychosocial factors and/or limiting SC factors) and successfully managed to deal with these problems, were able to achieve much better seizure control. This applied to 11 of the 16 patients (68%) by the end of the study (see bold figures in the last column of Table 4 ). Eight patients (50%) obtained an 80-100% reduction of their seizures, three of them (19%) are even seizure-free (for 2,2.5 and 3 years). Three other patients improved seizure control by 50-60%.
In nine of the 11 improved patients the improvement of seizure control could be obtained by parallel successful treatment of psychic factors and successful teaching or improvement of SC skills (indicated by + in columns 2 and 3 of Table 4 ). In addition, there are two patients (cases 3 and 14) who obtained a considerable success by only one kind of treatment; one of them even became seizure-free (for 30 months).
Of the remaining five patients (3 1%) two achieved only low (20-30%) seizure control, another patient high, but only temporary, control, and two patients almost no improvement of seizure control. There was not a single case of change for the worse during SC treatment.
The effect of the SC treatment was observed for at least 6 months (time of first follow-up), in most cases for 12 months (time of second follow-up), or even longer (up to 3 years).
Almost 70% of the 16 study patients with long-term intractable epilepsies were able to improve their seizure control to a considerable degree and with long-lasting effects. This was obtained by dealing with the seizureprovoking, situational and psychic stress factors and, if necessary, the functional value of seizures, by the overcoming of unfavourable reactions to warning signals and by developing-improving-individually tailored SC techniques to interrupt the outset of seizures.
As the approach to SC consists of a complex integrated therapy programme, it is difficult to determine the effect of each single SC component. However, this lack of specificity cannot annihilate the summarized positive result of the study that two-thirds of the patients, after many years of unsuccessful pharmacological treatment, could improve their seizure situation significantly while additionally applying non-medical behavioural measures of seizure control. We hope that these findings will encourage more SC treatment in more patients with epilepsy and will produce a broader database, which then can be analysed in a more detailed methodologically satisfying way.
From the fact that in most of our patients psychic stress factors were identified and could be improved by SC treatment, it could be asked whether these patients did not only have epileptic seizures but had non-epileptic (pseudo-) seizures as well and SC treatment improved the non-epileptic seizures in particular. But, as mentioned before (see methods), all patients had clear clinical and EEG evidence of epilepsy. In their long history of illness none of the patients had ever been diagnosed as having additional non-epileptic seizures. Beside this, it is generally accepted that psychic stress can be a risk factor for genuine epileptic seizures'* "7 "* t8-". Antibi and Bird*' differentiate between stress factors that evoke, or only facilitate, the development of epileptic seizures. They emphasize that sometimes it may be extremely difficult to show the relationship between stress factors and seizures, because stress may increase seizure liability, but a seizure develops only when one or more additional factors (e.g. a particular stimulus) intervenes. The authors propose an 'interactional model' of seizure development 'wherein, assuming a system is sensitive to a particular state or stimulus, the production of a seizure is dependent on the presentation of the stimulus . . . and the state of the system'".
This study offers detailed empirical evidence for the many variants of psychic stress which altered the state of our patients' system. The relationship between psychic stress and seizures could be shown to be twofold: the presence of stress factors at the beginning of the study related to a high seizure rate-the successful treatment of stress factors during the course (4 .) Another patient (case 15) only had GM seizures which began during sleep and no clear provoking factors could be identified.
(5 ) The fifth patient (case 16) had very weak warning signs at the beginning of the study which became even weaker after a change in her antiepileptic medication.
of the SC programme decreased the rate and severity of the seizures. In addition, Fenwick" and Fenwick and Brown" present a theoretical neurophysiological explanation of the effect of behavioural measures on seizure control by referring to an epilepsy model developed by Lockard".
The five patients with only poor or no improvement of seizure control do not disqualify the approach of self control. On the contrary, these cases can be explained in line with the approach. In all five patients adequate SC treatment could not be realized for the following different reasons.
(1) One patient (case 6, Table 4) decided to change medication and stop SC treatment.
(2) In case 5 there were strained relationships between family members: these could not be changed during the course of the study.
(3) One patient (case 1 1) had very strong and frightening aura feelings which prevented her from applying a control mechanism.
The first three reasons represent unforeseen complications, which could not be treated within the framework of the study. The fifth reason, however, points to an interesting and central aspect of SC which up to now has been neglected in studies of epilepsy: the possible interplay between SC and AED.
Though our study was not designed to examine this aspect, a closer look at the data reveals some more information on this topic which will be mentioned briefly. During the later phase of SC treatment 11 patients (nearly 70%) had changes in their antiepileptic medication. Except the one patient (case 6) mentioned above, who decided to change medication and stop SC, all other changes were decided upon by the patient, the physician and the SC therapist. Most of the patients agreed to inclusion criterion (g) of the study, i.e. to keep medication constant during SC treatment for at least 6 months. After that time, however, most of them wanted to continue searching for their optimal AEDs (in addition to SC therapy). Table 5 shows type and effect of changes in medication (column 4) in relation to type and effect of SC treatment (columns 2 and 3). In three cases ( 11, 15, 16) no positive effect was obtained by the change of medication. In three cases the change of AED improved the patient's possibilities of applying SC techniques and by that-with some weeks delay-seizure control improved as well. In two cases (1 and 3) the change had been from phenobarbital (PB), which has a strong sedative effect, to another less-sedating drug (lamotrigine (LTG) or valproate (VPA)) which made the patients more alert and enabled an earlier initiation of the control techniques. In the third case (10) warning signs which had disappeared under sulthiame (SLT) reappeared after a change to LTG. The remaining four patients had no change of type of drug but a partial reduction of their medication (see Q in column 4 of Table 5). Following dose reduction all four patients were able to improve their SC techniques and achieved further improvement of seizure control. One of them has been seizure-free for 2 years (under a minimal dose of 400 mg CBZ). These examples support the hypothesis that antiepileptic drugs may influence SC abilities and thus may have indirect effects on seizure control.
In summary, the presented findings support the idea of Reynolds, Bourgeois, Heinemann and others that epilepsy should be viewed as a process. At the same time the idea of process is further elaborated. Instead of dealing with 'the process of epilepsy' in general, this investigation dealt with the individual processes of patients with epilepsy. The approach of SC addresses the subject of the individual process. It aims at helping patients with epilepsy to learn to observe, understand and change their individual circumstances of seizure development. It activates the patients' own resources to increase seizure control-in addition to the pharmacological treatment of seizures.
Given the considerable success of nonpharmacological SC treatment in the I6 patients presented in this paper, and accepting possible interactions between psychological (behavioural) and pharmacological treatment effects in epilepsy. one has to ask if it is adequate to use the term 'intractable' or 'pharmacoresistant' to characterize these cases; the term 'difficult-to-treat' is suggested instead. Epilepsies have many causes and many factorsknown and unknown-that affect their further course of development. 'Difficult-to-treat' epilepsies are probably difficult to treat because particularly numerous factors are involved. Therefore, to control these complex processes of epilepsy a multimodal approach with well-coordinated different treatment components should be offered. Traditional pharmacological treatment alone-in monotherapy or in polytherapy-runs the risk of missing relevant factors.
An optimal therapy would be another kind of polytherapy consisting of a combination of pharmacological and SC therapy. This kind of synergistic treatment would be most effective if offered as early as possible after failure of first-choice drugs in monotherapy. With reference to Reynold's statement at the beginning of this article, it should be offered within the first 2 years of treatment-much earlier than it was offered to the study patients presented here.
